Total Payments
$102,996
2024 Payments
$2,732
Companies
100
Transactions
1,336
Medicare Patients
3,676
Medicare Billing
$305,521
Payment Breakdown by Category
Research$73,916 (71.8%)
Food & Beverage$23,227 (22.6%)
Travel$5,232 (5.1%)
Other$525.00 (0.5%)
Education$96.38 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $73,916 | 26 | 71.8% |
| Food and Beverage | $23,227 | 1,284 | 22.6% |
| Travel and Lodging | $5,232 | 14 | 5.1% |
| Honoraria | $400.00 | 1 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 0.1% |
| Education | $96.38 | 10 | 0.1% |
Payments by Type
Research
$73,916
26 transactions
General
$29,080
1,310 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orexo US, Inc. | $42,024 | 13 | $0 (2024) |
| PFIZER INC. | $31,387 | 56 | $0 (2024) |
| Novo Nordisk AS | $4,020 | 8 | $0 (2017) |
| Novo Nordisk Inc | $3,462 | 182 | $0 (2024) |
| ModernaTX, Inc. | $3,020 | 11 | $0 (2023) |
| ABBVIE INC. | $2,451 | 111 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,704 | 86 | $0 (2024) |
| Lilly USA, LLC | $984.58 | 73 | $0 (2024) |
| Merck Sharp & Dohme LLC | $782.96 | 70 | $0 (2023) |
| Bausch Health US, LLC | $751.27 | 56 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,732 | 143 | Novo Nordisk Inc ($368.48) |
| 2023 | $68,891 | 188 | Orexo US, Inc. ($32,414) |
| 2022 | $7,869 | 181 | Orexo US, Inc. ($4,512) |
| 2021 | $8,802 | 214 | Orexo US, Inc. ($5,000) |
| 2020 | $2,483 | 143 | Aytu Bioscience, Inc ($455.68) |
| 2019 | $3,169 | 164 | AbbVie, Inc. ($1,017) |
| 2018 | $2,470 | 125 | Novo Nordisk Inc ($455.76) |
| 2017 | $6,580 | 178 | Novo Nordisk AS ($4,020) |
All Payment Transactions
1,336 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $169.08 | General |
| Category: Durable Pump | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Neurology | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/12/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $24.30 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.82 | General |
| 10/30/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: HIV | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: DIABETES | ||||||
| 10/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| OXD01-001 | Orexo US, Inc. | $41,926 | 7 |
| PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND GROUP SEQUENTIAL PLACEBOCONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY OF RIMEGEPANT FOR THE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN CHILDREN AND ADOLESCENTS 6 TO 18 YEARS OF AGE | PFIZER INC. | $30,744 | 7 |
| M16-100 | AbbVie, Inc. | $999.72 | 11 |
| A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED, 4-WEEK CLINICAL ENDPOINT BIOEQUIVALENCE STUDY COMPARING FLUTICASONE PROPIONATE/SALMETEROL 100/50 MCG INHALATION POWDER (CIPLA LTD., INDIA) WITH ADVAIR DISKUS 100/50 MCG (GLAXOSMITHKLINE, USA) IN ASTHMA PATIENTS. | CIPLA USA INC. | $245.72 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 890 | 2,089 | $210,216 | $92,245 |
| 2022 | 19 | 950 | 1,461 | $173,064 | $74,775 |
| 2021 | 15 | 753 | 1,181 | $124,041 | $56,092 |
| 2020 | 21 | 1,083 | 1,981 | $182,135 | $82,410 |
Total Patients
3,676
Total Services
6,712
Medicare Billing
$305,521
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 471 | $70,575 | $28,032 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 166 | $29,050 | $12,740 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $24,380 | $11,236 | 46.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 179 | $11,635 | $8,000 | 68.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 35 | 187 | $14,025 | $6,316 | 45.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 173 | $16,435 | $5,915 | 36.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 43 | $5,805 | $3,916 | 67.5% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 62 | $4,650 | $3,020 | 64.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 18 | 19 | $9,500 | $2,642 | 27.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 14 | 68 | $4,420 | $2,179 | 49.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 73 | $4,015 | $2,040 | 50.8% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 55 | 65 | $3,900 | $1,657 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 41 | $2,255 | $1,644 | 72.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 97 | $2,910 | $830.22 | 28.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $651.00 | $571.29 | 87.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 48 | 49 | $1,715 | $443.62 | 25.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 20 | $700.00 | $438.00 | 62.6% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 19 | 23 | $460.00 | $213.18 | 46.3% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 13 | 14 | $490.00 | $195.16 | 39.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 33 | 33 | $495.00 | $112.53 | 22.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 21 | 21 | $420.00 | $90.09 | 21.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 12 | 173 | $1,730 | $15.11 | 0.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 310 | $54,250 | $24,265 | 44.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 129 | 129 | $34,185 | $16,209 | 47.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 252 | $31,500 | $14,402 | 45.7% |
About Steven Bauer
Steven Bauer is a Family Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053402875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steven Bauer has received a total of $102,996 in payments from pharmaceutical and medical device companies, with $2,732 received in 2024. These payments were reported across 1,336 transactions from 100 companies. The most common payment nature is "" ($73,916).
As a Medicare-enrolled provider, Bauer has provided services to 3,676 Medicare beneficiaries, totaling 6,712 services with total Medicare billing of $305,521. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Charlotte, NC
- Active Since 09/27/2006
- Last Updated 07/20/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053402875
Products in Payments
- NURTEC ODT (Drug) $31,668
- Victoza (Drug) $2,278
- Tresiba (Drug) $1,991
- Saxenda (Drug) $1,122
- FARXIGA (Drug) $1,111
- Androgel (Drug) $1,014
- Ozempic (Drug) $855.45
- JARDIANCE (Drug) $764.47
- UBRELVY (Drug) $732.29
- APLENZIN (Drug) $717.53
- XARELTO (Drug) $625.93
- Vascepa (Drug) $614.59
- Natesto (Drug) $545.43
- Wegovy (Drug) $446.06
- Kerendia (Drug) $407.84
- VRAYLAR (Drug) $382.43
- JANUVIA (Drug) $362.82
- XIFAXAN (Drug) $338.18
- Rybelsus (Drug) $334.91
- TRULICITY (Drug) $320.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Charlotte
Dr. Kevin Soden, Md, Mph, MD, MPH
Family Medicine — Payments: $582,495
Family Medicine $582,495
Richard Rachima, M.d, M.D
Family Medicine — Payments: $410,188
Family Medicine $410,188
Dr. Dimitrios Hondros, Md, MD
Family Medicine — Payments: $237,950
Family Medicine $237,950
Joseph Konen, Md, MD
Family Medicine — Payments: $232,457
Family Medicine $232,457
Dr. Thomas Barringer, Md, MD
Family Medicine — Payments: $199,434
Family Medicine $199,434
William Larsen, Md, MD
Family Medicine — Payments: $73,056
Family Medicine $73,056